TP53 and neoplasm: Differences in the genetic pattern of different tumor types may possibly be involved in modulating particular integrin subtypes since DU145 harbors mutations in CDKN2A, RB1, and TP53, whereas PC3 harbors mutations in PTEN and TP53.